Atlas Trials

Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects

Clinical trial NCT03065816 · COMPLETED

Trial details

NCT number
NCT03065816
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2017-02-09
Primary completion
2017-05-02
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.